TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

Rhea-AI Summary

TransMedics (Nasdaq: TMDX) will release fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026 after market close.

The company will host a management conference call at 4:30 p.m. ET / 1:30 p.m. PT with domestic dial-in (800) 715-9871, international (646) 307-1963 and access code 8036478. A live and archived webcast will be available on the company's Investors website.

News Market Reaction – TMDX

-4.30%

1 alert

-4.30% News Effect

On the day this news was published, TMDX declined 4.30%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Earnings release date: February 24, 2026 Conference call time ET: 4:30 p.m. ET Conference call time PT: 1:30 p.m. PT +3 more

6 metrics

Earnings release date February 24, 2026 Q4 and full year 2025 financial results release after market close

Conference call time ET 4:30 p.m. ET Start time for earnings conference call

Conference call time PT 1:30 p.m. PT Start time for earnings conference call

Access code 8036478 Investor dial-in access code for the conference call

Domestic dial-in (800) 715-9871 U.S. investor conference call number

International dial-in (646) 307-1963 International investor conference call number

Market Reality Check

Price: $134.25 Vol: Volume 609,279 vs 20-day ...

normal vol

$134.25 Last Close

Volume Volume 609,279 vs 20-day avg 807,057 (relative volume 0.75) ahead of the earnings date announcement. normal

Technical Shares at 136.34, trading above 200-day MA of 123.02, indicating a pre-news uptrend into the earnings date.

Peers on Argus

TMDX gained 0.95% while peers were mixed (e.g., ITGR -1.03%, BRKR +1.32%). No pe...

TMDX gained 0.95% while peers were mixed (e.g., ITGR -1.03%, BRKR +1.32%). No peers appeared in the momentum scanner and there were no same-day peer headlines, suggesting this scheduling update was stock-specific rather than part of a sector-wide move.

Historical Context

5 past events · Latest: Jan 12 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 12	HQ expansion lease	Positive	-1.8%	Long-term Somerville HQ lease and integrated campus with incentive packages.
Dec 30	Conference participation	Neutral	-0.2%	Participation in the 44th Annual J.P. Morgan Healthcare Conference.
Dec 24	Inducement grants	Neutral	-2.2%	Inducement stock options and RSUs granted to new employees.
Dec 09	Program expansion	Positive	-1.3%	Strategic collaboration to deploy a fleet and establish Italian OCS hubs.
Nov 18	Conference fireside chat	Neutral	+3.2%	Participation in Piper Sandler 37th Annual Healthcare Conference fireside chat.

Pattern Detected

Positive corporate expansion and partnership updates have twice coincided with negative next-day moves, while conference and routine governance items have seen modest, mostly aligned reactions.

Recent Company History

Over the last few months, TransMedics announced a new global headquarters campus with up to $18 million in state incentives and another $18 million in local tax relief, alongside plans to add up to 600 jobs. It has been active at major healthcare conferences and issued inducement equity grants. Earlier, it disclosed Italian National OCS Program hubs. These milestones reflect operational expansion and investor-relations activity, with today’s earnings-date notice fitting into a pattern of regular, non-financial updates between quarterly reports.

Market Pulse Summary

This announcement schedules TransMedics’ fourth quarter and full year 2025 results for February 24, ...

Analysis

This announcement schedules TransMedics’ fourth quarter and full year 2025 results for February 24, 2026, with a conference call at 4:30 p.m. ET. It follows recent updates on headquarters expansion, conference participation, and inducement grants. Investors tracking the story may focus on how upcoming results compare with previously reported quarterly performance and on any new guidance or strategic updates provided during the call and webcast.

AI-generated analysis. Not financial advice.

ANDOVER, Mass., Feb. 10, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the fourth quarter and full year 2025 after market close on Tuesday, February 24, 2026. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.

Investors interested in listening to the conference call may do so by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers and providing access code 8036478. A live and archived webcast of the event will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. 

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-24-2026-302684181.html

SOURCE TransMedics Group, Inc.

FAQ

When will TransMedics (TMDX) report Q4 and full year 2025 results?

TransMedics will report Q4 and full year 2025 results after market close on February 24, 2026. According to TransMedics, the company will follow the release with a management conference call at 4:30 p.m. ET to discuss results and answer investor questions.

How can investors join the TransMedics (TMDX) earnings call on February 24, 2026?

Investors can join the TransMedics earnings call by dialing (800) 715-9871 domestic or (646) 307-1963 international with access code 8036478. According to TransMedics, a live and archived webcast will also be available on the Investors section of the company website.

What time is the TransMedics (TMDX) conference call for the 2025 results?

The TransMedics conference call is scheduled for 4:30 p.m. ET / 1:30 p.m. PT on February 24, 2026. According to TransMedics, management will present the results on the call and provide a live webcast and archived replay on the investor website.

Where will the TransMedics (TMDX) webcast of the February 24, 2026 call be available?

The live and archived webcast will be available on the Investors section of the TransMedics website at https://investors.transmedics.com/. According to TransMedics, the webcast will host the management presentation and an archived replay after the call concludes.

Will TransMedics (TMDX) provide an archived replay of the Q4 2025 earnings call?

Yes, TransMedics will provide an archived webcast replay of the Q4 2025 earnings call on its investor website. According to TransMedics, the archived webcast will be posted after the live event for investor access and review.